Pathophysiology and treatment of obesity-related hypertension

被引：38
作者：
Chrysant, Steven G. [1 ]
机构：
[1] Univ Oklahoma, Hlth Sci Ctr, 5700 Mistletoe Court, Oklahoma City, OK 73142 USA
来源：
JOURNAL OF CLINICAL HYPERTENSION | 2019年 / 21卷 / 05期
关键词：
hypertension; mechanisms; obesity; treatment; NATRIURETIC PEPTIDES; KIDNEY-DISEASE; LEPTIN LEVEL; FAT; MECHANISMS; PRESSURE; SYSTEM; RISK; ALDOSTERONE; EXPRESSION;
D O I：
10.1111/jch.13518
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
The prevalence of overweight and obesity has increased significantly in the United States and worldwide. Among the many complications of obesity, hypertension is the most common and major one accounting for about 70% in the obese subjects. However, the pathophysiologic factors of obesity-related hypertension and its therapeutic options are not well understood at present. To better understand the pathophysiology of obesity-related hypertension and its treatment options, a Medline search of the English language literature was contacted between 2010 and 2018 and 22 pertinent papers were selected. The information from these papers together with collateral literature will be discussed in this review.
引用
收藏
页码：555 / 559
页数：5
相关论文
共 50 条
  • [41] Gut microbiome: Microflora association with obesity and obesity-related comorbidities
    Lone, Jameel Barkat
    Koh, Wee Yin
    Parray, Hilal A.
    Paek, Woon K.
    Lim, Jeongheui
    Rather, Irfan A.
    Jan, Arif Tasleem
    MICROBIAL PATHOGENESIS, 2018, 124 : 266 - 271
  • [42] Effect of adrenomedullin on obesity-related hypertension
    Mogi, Masaki
    HYPERTENSION RESEARCH, 2024, 47 (08) : 2221 - 2222
  • [43] Role of inflammation in obesity-related breast cancer
    Crespi, Elisa
    Bottai, Giulia
    Santarpia, Libero
    CURRENT OPINION IN PHARMACOLOGY, 2016, 31 : 114 - 122
  • [44] Manifestation of renal disease in obesity: pathophysiology of obesity-related dysfunction of the kidney
    D'Elia, John A.
    Roshan, Bijan
    Maski, Manish
    Weinrauch, Larry A.
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2009, 2 : 39 - 49
  • [45] Pravastatin alleviates allergic airway inflammation in obesity-related asthma mouse model
    Lee, Hwa Young
    Lee, Eung Gu
    Hur, Jung
    Rhee, Chin Kook
    Kim, Young Kyoon
    Lee, Sook Young
    Kang, Ji Young
    EXPERIMENTAL LUNG RESEARCH, 2019, 45 (9-10) : 275 - 287
  • [46] Leptin association with erythrocyte sodium content in obesity-related hypertension
    Barroso, SG
    de Abreu, VG
    Sanjuliani, AF
    Rodrigues, MDG
    Francischetti, EA
    TRACE ELEMENTS AND ELECTROLYTES, 2003, 20 (02) : 134 - 139
  • [47] The impact of obesity-related raised intracranial pressure in rodents
    Westgate, Connar Stanley James
    Hagen, Snorre Malm
    Israelsen, Ida Marchen Egerod
    Hamann, Steffen
    Jensen, Rigmor Hojland
    Eftekhari, Sajedeh
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [48] Neural mechanisms in human obesity-related hypertension
    Rumantir, MS
    Vaz, M
    Jennings, GL
    Collier, G
    Kaye, DM
    Seals, DR
    Wiesner, GH
    Brunner-La Rocca, HP
    Esler, MD
    JOURNAL OF HYPERTENSION, 1999, 17 (08) : 1125 - 1133
  • [49] Correlation between obesity-related indices and hypertension
    Zhao, Guangyi
    Zhou, Zhiyi
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (08): : 3842 - 3850
  • [50] Hydralazine as antihypertensive therapy in obesity-related hypertension
    J F Carroll
    J W King
    J S Cohen
    International Journal of Obesity, 2004, 28 : 384 - 390
12345